The assay of seminal AMH may be considered as a tool for prediction of gonadotropin therapy outcome in hypogonadotropic hypogonadism, since its early increase may be a marker of good spermatogenic response [23]. The gene discussed is AMH; the disease is hypogonadotropic hypogonadism.